Aspira Women’s Health Inc. (NASDAQ:AWH) Short Interest Update

Aspira Women’s Health Inc. (NASDAQ:AWH) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 169,400 shares, a growth of 26.2% from the March 31st total of 134,200 shares. Based on an average daily volume of 27,900 shares, the days-to-cover ratio is currently 6.1 days. Currently, 2.5% of the company’s shares are sold short.

Aspira Women’s Health Stock Performance

Aspira Women’s Health stock traded down $0.11 during trading hours on Tuesday, hitting $3.22. 9,565 shares of the stock were exchanged, compared to its average volume of 29,550. The business’s 50-day moving average is $3.55 and its two-hundred day moving average is $3.97. Aspira Women’s Health has a 12 month low of $2.31 and a 12 month high of $6.75. The stock has a market capitalization of $39.73 million, a P/E ratio of -0.27 and a beta of 1.61.

Aspira Women’s Health (NASDAQ:AWH) last announced its quarterly earnings data on Thursday, March 28th. The company reported ($0.30) EPS for the quarter, topping analysts’ consensus estimates of ($0.39) by $0.09. The firm had revenue of $2.13 million during the quarter, compared to analyst estimates of $2.70 million. Aspira Women’s Health had a negative return on equity of 1,099.32% and a negative net margin of 176.74%. On average, equities analysts predict that Aspira Women’s Health will post -1.24 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the stock. Quantum Private Wealth LLC lifted its stake in Aspira Women’s Health by 76.8% in the fourth quarter. Quantum Private Wealth LLC now owns 50,156 shares of the company’s stock valued at $205,000 after acquiring an additional 21,788 shares during the last quarter. Northeast Financial Consultants Inc acquired a new position in shares of Aspira Women’s Health during the 3rd quarter worth approximately $126,000. B. Riley Wealth Advisors Inc. increased its stake in Aspira Women’s Health by 39.0% during the 3rd quarter. B. Riley Wealth Advisors Inc. now owns 125,374 shares of the company’s stock worth $672,000 after acquiring an additional 35,177 shares during the period. Finally, Perkins Capital Management Inc. acquired a new position in Aspira Women’s Health in the third quarter valued at about $268,000. Institutional investors own 12.19% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on AWH. StockNews.com began coverage on shares of Aspira Women’s Health in a research report on Saturday. They issued a “hold” rating for the company. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $3.30 target price on shares of Aspira Women’s Health in a research report on Wednesday, April 10th.

About Aspira Women’s Health

Aspira Women's Health Inc, together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company's products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering.